Clinical Trial Update: Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharmacokinetics and pharmacogenetics-based adaptive dosing of 5-fluorouracil during TPF therapy in head and neck cancer; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Patients With Head and Neck Cancer (ORL) | Phase 4 | Status: COMPLETED